Kari Tikkinen, MD, PhD, discusses POISE-3 findings showing tranexamic acid reduced major bleeding without significantly increasing thrombotic events in urologic surgery.
Kari A.O. Tikkinen, MD, PhD
Advertisement
Tikkinen is a professor of urology & clinical epidemiology & public health and Head of Section (Urology) at the University of Helsinki in Finland.
Articles by Kari A.O. Tikkinen, MD, PhD
In this interview, Kari A.O. Tikkinen, MD, PhD, explains why effective nocturia management in geriatric patients requires systematic phenotyping across 4 primary subtypes—nocturnal polyuria, reduced bladder capacity, bladder outlet obstruction, and sleep-driven causes—rather than empiric pharmacologic treatment, with many cases requiring interdisciplinary referral rather than urologic intervention alone.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Urology Times
1
FDA grants breakthrough therapy, fast track designations to kidney cancer imaging agent
2
Mary Dunn, MSN, NP-C, OCN, RN, on advances reshaping advanced prostate cancer care
3
The Expert APProach: Advancing APP Leadership and Expertise in Urology, With Susanne Quallich, PhD, ANP-BC, NP-C
4
Managing Immune-Related Adverse Events With Durvalumab Plus BCG in NMIBC
5